Buyout PE
ChrysCapital
ChrysCapital acquires controlling stakes in established, profitable businesses, from Mauritius. It states a focus on consumer & retail, software & internet, financial services and healthcare & life sciences.
Stated investment criteria
What ChrysCapital says it buys
Read from ChrysCapital’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.
A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. ChrysCapital states that it will take either a controlling or a minority stake. The team figure counts the people the firm shows on one team page, so it is a floor rather than a headcount: firms that split their team across tabs or load it in pages will read low. Nothing here is a commitment by ChrysCapital to consider any particular business, and nothing on this page is represented as being for sale.
Regulatory record
How ChrysCapital is registered
From this firm's Form ADV, the annual filing every registered and exempt investment adviser makes to the SEC.
| Adviser status | Exempt reporting adviser |
| Regulatory assets under management | Not reported by an ERA |
| Private funds advised | 1 · $1.7bn gross |
| SEC adviser number | CRD 336320 |
An exempt reporting adviser is not required to report regulatory assets under management, so the blank above means the question was not asked rather than that the answer is unknown. Where a figure exists it is the gross asset value of the private funds the firm advises, which is a different and usually larger measure.
Portfolio
Disclosed holdings
Companies ChrysCapital lists on its own website. No investment years are published.
| Company | Invested | Years held | Recorded transaction |
|---|---|---|---|
| AU Small Finance Bank | — | — | — |
| CavinKare | — | — | — |
| Cyient | — | — | — |
| GeBBS Healthcare | — | — | — |
| HCL Tech | — | — | — |
| Infogain | — | — | — |
| Infosys | — | — | — |
| LTIMindtree | — | — | — |
| Lenskart | — | — | — |
| LiquidHub | — | — | — |
| Mahindra Finance | — | — | — |
| Mankind Pharma | — | — | — |
| MoEngage | — | — | — |
| Mphasis | — | — | — |
| Nseindia | — | — | — |
| ProHance | — | — | — |
| Quest Global | — | — | — |
| Redington Group | — | — | — |
| ResultsCX | — | — | — |
| Shriram Finance | — | — | — |
| SpectraMind Solutions | — | — | — |
| WOW Skin Science | — | — | — |
| Xoriant | — | — | — |
| aubank.in | — | — | — |
| curatio-healthcare.com | — | — | — |
| eris.co.in | — | — | — |
| gvk.com | — | — | — |
| intaspharma.com | — | — | — |
| torrentpharma.com | — | — | — |
Compiled from ChrysCapital’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.
Recorded transactions
Buying and selling
Deals in which ChrysCapital is named as buyer or seller in the transaction archive. 2 recorded exits, most recently in 2024. 1 recorded acquisition.
| Company | Side | Counterparty | Year | Consideration |
|---|---|---|---|---|
| Eris Lifesciences | Sold | — | 2024 | $179m |
| Curatio Healthcare | Sold | Torrent Pharmaceuticals | 2022 | $301m |
| Safex Chemicals India | Bought | BanyanTree Finance Pvt. Ltd. | 2021 | $50m |
Compiled from a transaction archive of 10,204 recorded deals. Most private transactions are never disclosed, so this is a sample of a firm’s activity rather than a complete record of it.
Valuation context
Transaction values in Consumer & Retail
What companies have actually sold for in consumer & retail, across 837 recorded transactions.
The full consumer & retail picture - most active acquirers, recent transactions and every investor in the sector.
For owners
Own a consumer & retail business?
The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.
Request a confidential valuationFor investors
Is this ChrysCapital?
Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.
Claim or correct this profileTargeted buyer search
Which hundred of these would actually buy your business?
A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.
Comparable investors
Similar mandates
Other buyout pe investors active in consumer & retail.